Thryv Therapeutics
Thryv Therapeutics
thryvtrx.com

Locations

Laval, QC, Canada · Montreal, QC, Canada · Montréal, QC, Canada

industry

Biotechnology

Size

11 - 50 employees

Stage

Other

founded in

2019

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T wave and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.

Something looks off?
Open jobs at Thryv Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.